HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

ITQACPKVSFEPIPHYCAPAGFAI gp160(201-225) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
 TQACPKVSFEPIPIHYCAPA gp160(202-221) human epitope
    CPKVSFEPIPIHYCA gp160(205-219) mouse epitope
     PKVTFEPIPIRYCAP gp160(206-220) A*29:02 human epitope
     PKVsFEPIPIhYCAP gp160(206-220) non-susceptible form
     PKVSFEPIPIHYCAP gp160(206-220) human, mouse epitope
      KVSFDPIPIHYCAPAGYA gp160(207-224) C*04 human epitope
      KVSFDPIPIHYCAPAGYA gp160(207-224) C*04:01 human epitope
       VSFEPIPIHY gp160(208-217) A29 human epitope
       VSFEPIPIHY gp160(208-217) A29 human epitope
       VSFEPIPIHY gp160(208-217) A29 human epitope
       VSFEPIPPHYCA gp160(208-219) A2 human epitope
       VSFEPIPPHYCA gp160(208-219) A2 human epitope
        SFDPIPIHY gp160(209-217) A*29 human epitope
        SFnPIPIHY gp160(209-217) observed variant
        tFDPIPIHY gp160(209-217) literature escape
        SFDPlPIHY gp160(209-217) observed variant
        SFDPIPIHY gp160(209-217) A*29 human epitope
        SFEPIPIHY gp160(209-217) A*29 epitope
        SFEPIPIHY gp160(209-217) A*29 human epitope
        SFEPIPIHY gp160(209-217) A29 human epitope
        SFDPIPIHY gp160(209-217) A29 human epitope
        SFEPIPIHY gp160(209-217) A29 human epitope
        SFDPIPIHY gp160(209-217) A29 human epitope
        SFEPIPIHY gp160(209-217) A29 human epitope
        SFEPIPIHY gp160(209-217) A29 human epitope
        SFEPIPIHY gp160(209-217) A*29:02 human epitope
        SFEPIPIHY gp160(209-217) A*29:02 human epitope
        SFEPIPIHY gp160(209-217) A*29:02 human epitope
        SFdPIPIHY gp160(209-217) diminished response
        SFEPIPIHf gp160(209-217) diminished response
        SiEPIPIHf gp160(209-217) diminished response
        tFEPIPIHY gp160(209-217) diminished response
        SsEPIPIHY gp160(209-217) observed variant
        SFEPIPInY gp160(209-217) observed variant
        SFEPIPIdf gp160(209-217) observed variant
        SFEPIPIHY gp160(209-217) B*14 human epitope
        SFEPIPIHY gp160(209-217) B*58:01 human epitope
        SFEPIPIHY gp160(209-217) B*82 human epitope
        SFEPIPIHY gp160(209-217) C*18 human epitope
        SFDPIPIHF gp160(209-217) human epitope
        SFEPIPIHY gp160(209-217) human epitope
        SFEPIPIHY gp160(209-217) human epitope
        SFEPIPIHY gp160(209-217) human, mouse epitope
           PIPIHYCAPAGFAIL gp160(212-226) human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) A2 human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) A2 human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) B57 human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) human epitope
           PIPIHYCAPAGFAILKCNNK gp160(212-231) human epitope
            IPIHYCAPA gp160(213-221) B*07:02 human epitope
            IPIHYCAPA gp160(213-221) B7 human epitope
            IPIHYCAPA gp160(213-221) B7 human epitope
            IPIHYCAPA gp160(213-221) B7 supertype human, mouse epitope
            IPIHYCAPAGFAILKCNN gp160(213-230) human epitope
            IPIHYCAPAGFAILKCNdKK gp160(213-230) observed variant
            IPIHYCAPAGFAILKCNDKK gp160(213-232) human epitope
            IPIHYCAPAGFAILKCNn gp160(213-232) observed variant
              IHYCAPAGYAILKCNNKTF gp160(215-233) C*12 human epitope
               HYCAPAGFAIL gp160(216-226) human epitope
                YCAPAGFAIL gp160(217-226) C*01 human epitope
                YCAPAGFAIi gp160(217-226) escape documented in this paper; replicative capacity is not abrogated
                YCAPAGlAIi gp160(217-226) escape documented in this paper
                YCtPAGFAIi gp160(217-226) escape documented in this paper
                YCAPAGFAni gp160(217-226) escape documented in this paper
                YCAPAGFtIi gp160(217-226) escape documented in this paper
                YCAPAGFAIL gp160(217-226) C*01 human epitope
                YCAPAGFAIL gp160(217-226) C*01:02 human epitope
                YCAPAGFAIL gp160(217-226) C*01:02 human epitope
                YCAPAGFAIi gp160(217-226) escape documented in this paper
                YCAPAGFAIL gp160(217-226) C*01:02 human epitope
                YCAPAGFAIi gp160(217-226) escape documented in this paper
                YCAPAGFAIL gp160(217-226) C*01:02 human epitope
                YCAPAGFAIL gp160(217-226) C*01:02 human epitope
                YCAPAGFAIi gp160(217-226) escape documented in this paper
                YCAPAGFAIL gp160(217-226) Cw1 human epitope
                 CAPAGFAIL gp160(218-226) C*01 human epitope
                 CAPAGFAIL gp160(218-226) Cw1 human epitope
                 CtPAGFAIL gp160(218-226) susceptible form
                 CtPAGFtIL gp160(218-226) escape documented in this paper
                 CtPAGFvIL gp160(218-226) escape documented in this paper
                 CAPAGFAIL gp160(218-226) human epitope
                 CtPAGFAIL gp160(218-226) susceptible form; subtype-specific susceptible form
                 CAPAGyAIL gp160(218-226) susceptible form; subtype-specific susceptible form
                 CTPAGYAILKC gp160(218-228) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health